The latest research study released by Market IntelliX evaluates market size and forecasts of Home Insulin Delivery (Dosing) Devices in global, including the following market information:

Global Home Insulin Delivery (Dosing) Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Home Insulin Delivery (Dosing) Devices Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Home Insulin Delivery (Dosing) Devices companies in 2021 (%)

The global Home Insulin Delivery (Dosing) Devices market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Insulin Pens Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Home Insulin Delivery (Dosing) Devices include Tandem Diabetes Care, Biocon, Roche Holding AG, Insulet Corporation, B. Braun, BD, Eli Lilly and Company, Novo Nordisk and Sanofi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MI has surveyed the Home Insulin Delivery (Dosing) Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Market Segmentations:

Global Home Insulin Delivery (Dosing) Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Home Insulin Delivery (Dosing) Devices Market Segment Percentages, by Type, 2021 (%)

Insulin Pens

Insulin Pumps

Insulin Syringes

Others

Global Home Insulin Delivery (Dosing) Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Home Insulin Delivery (Dosing) Devices Market Segment Percentages, by Application, 2021 (%)

Hospitals Pharmacy

Online Pharmacy

Retail Pharmacy

Global Home Insulin Delivery (Dosing) Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Home Insulin Delivery (Dosing) Devices Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Home Insulin Delivery (Dosing) Devices revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Home Insulin Delivery (Dosing) Devices revenues share in global market, 2021 (%)

Key companies Home Insulin Delivery (Dosing) Devices sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Home Insulin Delivery (Dosing) Devices sales share in global market, 2021 (%)

The report presents profiles of competitors in the market, Some of the prominent key players covered:

Tandem Diabetes Care

Biocon

Roche Holding AG

Insulet Corporation

B. Braun

BD

Eli Lilly and Company

Novo Nordisk

Sanofi

Wockhardt

Ypsomed Holding

Medtronic

Julphar

Beta Bionics

Copernicus

Dance Biopharm

Debiotech

MannKind

Owen Mumford

SOOIL

Valeritas

West Pharma

Key Takeaways from this Report

Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.

Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.

Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.

Analyze the sales and distribution channels across key geographies to improve top-line revenues.

Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.

Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.

Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.

1 Introduction to Research & Analysis Reports

1.1 Home Insulin Delivery (Dosing) Devices Market Definition

1.2 Market Segments

1.2.1 Market by Type

1.2.2 Market by Application

1.3 Global Home Insulin Delivery (Dosing) Devices Market Overview

1.4 Features & Benefits of This Report

1.5 Methodology & Sources of Information

1.5.1 Research Methodology

1.5.2 Research Process

1.5.3 Base Year

1.5.4 Report Assumptions & Caveats

2 Global Home Insulin Delivery (Dosing) Devices Overall Market Size

2.1 Global Home Insulin Delivery (Dosing) Devices Market Size: 2021 VS 2028

2.2 Global Home Insulin Delivery (Dosing) Devices Revenue, Prospects & Forecasts: 2017-2028

2.3 Global Home Insulin Delivery (Dosing) Devices Sales: 2017-2028

3 Company Landscape

3.1 Top Home Insulin Delivery (Dosing) Devices Players in Global Market

3.2 Top Global Home Insulin Delivery (Dosing) Devices Companies Ranked by Revenue

3.3 Global Home Insulin Delivery (Dosing) Devices Revenue by Companies

3.4 Global Home Insulin Delivery (Dosing) Devices Sales by Companies

3.5 Global Home Insulin Delivery (Dosing) Devices Price by Manufacturer (2017-2022)

3.6 Top 3 and Top 5 Home Insulin Delivery (Dosing) Devices Companies in Global Market, by Revenue in 2021

3.7 Global Manufacturers Home Insulin Delivery (Dosing) Devices Product Type

3.8 Tier 1, Tier 2 and Tier 3 Home Insulin Delivery (Dosing) Devices Players in Global Market

3.8.1 List of Global Tier 1 Home Insulin Delivery (Dosing) Devices Companies

3.8.2 List of Global Tier 2 and Tier 3 Home Insulin Delivery (Dosing) Devices Companies

4 Sights by Product

4.1 Overview

4.1.1 By Type - Global Home Insulin Delivery (Dosing) Devices Market Size Markets, 2021 & 2028

4.1.2 Insulin Pens

4.1.3 Insulin Pumps

4.1.4 Insulin Syringes

4.1.5 Others

4.2 By Type - Global Home Insulin Delivery (Dosing) Devices Revenue & Forecasts

4.2.1 By Type - Global Home Insulin Delivery (Dosing) Devices Revenue, 2017-2022

4.2.2 By Type - Global Home Insulin Delivery (Dosing) Devices Revenue, 2023-2028

4.2.3 By Type - Global Home Insulin Delivery (Dosing) Devices Revenue Market Share, 2017-2028

4.3 By Type - Global Home Insulin Delivery (Dosing) Devices Sales & Forecasts

4.3.1 By Type - Global Home Insulin Delivery (Dosing) Devices Sales, 2017-2022

4.3.2 By Type - Global Home Insulin Delivery (Dosing) Devices Sales, 2023-2028

4.3.3 By Type - Global Home Insulin Delivery (Dosing) Devices Sales Market Share, 2017-2028

4.4 By Type - Global Home Insulin Delivery (Dosing) Devices Price (Manufacturers Selling Prices), 2017-2028

5 Sights By Application

5.1 Overview

5.1.1 By Application - Global Home Insulin Delivery (Dosing) Devices Market Size, 2021 & 2028

5.1.2 Hospitals Pharmacy

5.1.3 Online Pharmacy

5.1.4 Retail Pharmacy

5.2 By Application - Global Home Insulin Delivery (Dosing) Devices Revenue & Forecasts

5.2.1 By Application - Global Home Insulin Delivery (Dosing) Devices Revenue, 2017-2022

5.2.2 By Application - Global Home Insulin Delivery (Dosing) Devices Revenue, 2023-2028

5.2.3 By Application - Global Home Insulin Delivery (Dosing) Devices Revenue Market Share, 2017-2028

5.3 By Application - Global Home Insulin Delivery (Dosing) Devices Sales & Forecasts

5.3.1 By Application - Global Home Insulin Delivery (Dosing) Devices Sales, 2017-2022

5.3.2 By Application - Global Home Insulin Delivery (Dosing) Devices Sales, 2023-2028

5.3.3 By Application - Global Home Insulin Delivery (Dosing) Devices Sales Market Share, 2017-2028

5.4 By Application - Global Home Insulin Delivery (Dosing) Devices Price (Manufacturers Selling Prices), 2017-2028

6 Sights by Region

6.1 By Region - Global Home Insulin Delivery (Dosing) Devices Market Size, 2021 & 2028

6.2 By Region - Global Home Insulin Delivery (Dosing) Devices Revenue & Forecasts

6.2.1 By Region - Global Home Insulin Delivery (Dosing) Devices Revenue, 2017-2022

6.2.2 By Region - Global Home Insulin Delivery (Dosing) Devices Revenue, 2023-2028

6.2.3 By Region - Global Home Insulin Delivery (Dosing) Devices Revenue Market Share, 2017-2028

6.3 By Region - Global Home Insulin Delivery (Dosing) Devices Sales & Forecasts

6.3.1 By Region - Global Home Insulin Delivery (Dosing) Devices Sales, 2017-2022

6.3.2 By Region - Global Home Insulin Delivery (Dosing) Devices Sales, 2023-2028

6.3.3 By Region - Global Home Insulin Delivery (Dosing) Devices Sales Market Share, 2017-2028

6.4 North America

6.4.1 By Country - North America Home Insulin Delivery (Dosing) Devices Revenue, 2017-2028

6.4.2 By Country - North America Home Insulin Delivery (Dosing) Devices Sales, 2017-2028

6.4.3 US Home Insulin Delivery (Dosing) Devices Market Size, 2017-2028

6.4.4 Canada Home Insulin Delivery (Dosing) Devices Market Size, 2017-2028

6.4.5 Mexico Home Insulin Delivery (Dosing) Devices Market Size, 2017-2028

6.5 Europe

6.5.1 By Country - Europe Home Insulin Delivery (Dosing) Devices Revenue, 2017-2028

6.5.2 By Country - Europe Home Insulin Delivery (Dosing) Devices Sales, 2017-2028

6.5.3 Germany Home Insulin Delivery (Dosing) Devices Market Size, 2017-2028

6.5.4 France Home Insulin Delivery (Dosing) Devices Market Size, 2017-2028

6.5.5 U.K. Home Insulin Delivery (Dosing) Devices Market Size, 2017-2028

6.5.6 Italy Home Insulin Delivery (Dosing) Devices Market Size, 2017-2028

6.5.7 Russia Home Insulin Delivery (Dosing) Devices Market Size, 2017-2028

6.5.8 Nordic Countries Home Insulin Delivery (Dosing) Devices Market Size, 2017-2028

6.5.9 Benelux Home Insulin Delivery (Dosing) Devices Market Size, 2017-2028

6.6 Asia

6.6.1 By Region - Asia Home Insulin Delivery (Dosing) Devices Revenue, 2017-2028

6.6.2 By Region - Asia Home Insulin Delivery (Dosing) Devices Sales, 2017-2028

6.6.3 China Home Insulin Delivery (Dosing) Devices Market Size, 2017-2028

6.6.4 Japan Home Insulin Delivery (Dosing) Devices Market Size, 2017-2028

6.6.5 South Korea Home Insulin Delivery (Dosing) Devices Market Size, 2017-2028

6.6.6 Southeast Asia Home Insulin Delivery (Dosing) Devices Market Size, 2017-2028

6.6.7 India Home Insulin Delivery (Dosing) Devices Market Size, 2017-2028

6.7 South America

6.7.1 By Country - South America Home Insulin Delivery (Dosing) Devices Revenue, 2017-2028

6.7.2 By Country - South America Home Insulin Delivery (Dosing) Devices Sales, 2017-2028

6.7.3 Brazil Home Insulin Delivery (Dosing) Devices Market Size, 2017-2028

6.7.4 Argentina Home Insulin Delivery (Dosing) Devices Market Size, 2017-2028

6.8 Middle East & Africa

6.8.1 By Country - Middle East & Africa Home Insulin Delivery (Dosing) Devices Revenue, 2017-2028

6.8.2 By Country - Middle East & Africa Home Insulin Delivery (Dosing) Devices Sales, 2017-2028

6.8.3 Turkey Home Insulin Delivery (Dosing) Devices Market Size, 2017-2028

6.8.4 Israel Home Insulin Delivery (Dosing) Devices Market Size, 2017-2028

6.8.5 Saudi Arabia Home Insulin Delivery (Dosing) Devices Market Size, 2017-2028

6.8.6 UAE Home Insulin Delivery (Dosing) Devices Market Size, 2017-2028

7 Manufacturers & Brands Profiles

7.1 Tandem Diabetes Care

7.1.1 Tandem Diabetes Care Corporate Summary

7.1.2 Tandem Diabetes Care Business Overview

7.1.3 Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Major Product Offerings

7.1.4 Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Sales and Revenue in Global (2017-2022)

7.1.5 Tandem Diabetes Care Key News

7.2 Biocon

7.2.1 Biocon Corporate Summary

7.2.2 Biocon Business Overview

7.2.3 Biocon Home Insulin Delivery (Dosing) Devices Major Product Offerings

7.2.4 Biocon Home Insulin Delivery (Dosing) Devices Sales and Revenue in Global (2017-2022)

7.2.5 Biocon Key News

7.3 Roche Holding AG

7.3.1 Roche Holding AG Corporate Summary

7.3.2 Roche Holding AG Business Overview

7.3.3 Roche Holding AG Home Insulin Delivery (Dosing) Devices Major Product Offerings

7.3.4 Roche Holding AG Home Insulin Delivery (Dosing) Devices Sales and Revenue in Global (2017-2022)

7.3.5 Roche Holding AG Key News

7.4 Insulet Corporation

7.4.1 Insulet Corporation Corporate Summary

7.4.2 Insulet Corporation Business Overview

7.4.3 Insulet Corporation Home Insulin Delivery (Dosing) Devices Major Product Offerings

7.4.4 Insulet Corporation Home Insulin Delivery (Dosing) Devices Sales and Revenue in Global (2017-2022)

7.4.5 Insulet Corporation Key News

7.5 B. Braun

7.5.1 B. Braun Corporate Summary

7.5.2 B. Braun Business Overview

7.5.3 B. Braun Home Insulin Delivery (Dosing) Devices Major Product Offerings

7.5.4 B. Braun Home Insulin Delivery (Dosing) Devices Sales and Revenue in Global (2017-2022)

7.5.5 B. Braun Key News

7.6 BD

7.6.1 BD Corporate Summary

7.6.2 BD Business Overview

7.6.3 BD Home Insulin Delivery (Dosing) Devices Major Product Offerings

7.6.4 BD Home Insulin Delivery (Dosing) Devices Sales and Revenue in Global (2017-2022)

7.6.5 BD Key News

7.7 Eli Lilly and Company

7.7.1 Eli Lilly and Company Corporate Summary

7.7.2 Eli Lilly and Company Business Overview

7.7.3 Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Major Product Offerings

7.7.4 Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Sales and Revenue in Global (2017-2022)

7.7.5 Eli Lilly and Company Key News

7.8 Novo Nordisk

7.8.1 Novo Nordisk Corporate Summary

7.8.2 Novo Nordisk Business Overview

7.8.3 Novo Nordisk Home Insulin Delivery (Dosing) Devices Major Product Offerings

7.8.4 Novo Nordisk Home Insulin Delivery (Dosing) Devices Sales and Revenue in Global (2017-2022)

7.8.5 Novo Nordisk Key News

7.9 Sanofi

7.9.1 Sanofi Corporate Summary

7.9.2 Sanofi Business Overview

7.9.3 Sanofi Home Insulin Delivery (Dosing) Devices Major Product Offerings

7.9.4 Sanofi Home Insulin Delivery (Dosing) Devices Sales and Revenue in Global (2017-2022)

7.9.5 Sanofi Key News

7.10 Wockhardt

7.10.1 Wockhardt Corporate Summary

7.10.2 Wockhardt Business Overview

7.10.3 Wockhardt Home Insulin Delivery (Dosing) Devices Major Product Offerings

7.10.4 Wockhardt Home Insulin Delivery (Dosing) Devices Sales and Revenue in Global (2017-2022)

7.10.5 Wockhardt Key News

7.11 Ypsomed Holding

7.11.1 Ypsomed Holding Corporate Summary

7.11.2 Ypsomed Holding Home Insulin Delivery (Dosing) Devices Business Overview

7.11.3 Ypsomed Holding Home Insulin Delivery (Dosing) Devices Major Product Offerings

7.11.4 Ypsomed Holding Home Insulin Delivery (Dosing) Devices Sales and Revenue in Global (2017-2022)

7.11.5 Ypsomed Holding Key News

7.12 Medtronic

7.12.1 Medtronic Corporate Summary

7.12.2 Medtronic Home Insulin Delivery (Dosing) Devices Business Overview

7.12.3 Medtronic Home Insulin Delivery (Dosing) Devices Major Product Offerings

7.12.4 Medtronic Home Insulin Delivery (Dosing) Devices Sales and Revenue in Global (2017-2022)

7.12.5 Medtronic Key News

7.13 Julphar

7.13.1 Julphar Corporate Summary

7.13.2 Julphar Home Insulin Delivery (Dosing) Devices Business Overview

7.13.3 Julphar Home Insulin Delivery (Dosing) Devices Major Product Offerings

7.13.4 Julphar Home Insulin Delivery (Dosing) Devices Sales and Revenue in Global (2017-2022)

7.13.5 Julphar Key News

7.14 Beta Bionics

7.14.1 Beta Bionics Corporate Summary

7.14.2 Beta Bionics Business Overview

7.14.3 Beta Bionics Home Insulin Delivery (Dosing) Devices Major Product Offerings

7.14.4 Beta Bionics Home Insulin Delivery (Dosing) Devices Sales and Revenue in Global (2017-2022)

7.14.5 Beta Bionics Key News

7.15 Copernicus

7.15.1 Copernicus Corporate Summary

7.15.2 Copernicus Business Overview

7.15.3 Copernicus Home Insulin Delivery (Dosing) Devices Major Product Offerings

7.15.4 Copernicus Home Insulin Delivery (Dosing) Devices Sales and Revenue in Global (2017-2022)

7.15.5 Copernicus Key News

7.16 Dance Biopharm

7.16.1 Dance Biopharm Corporate Summary

7.16.2 Dance Biopharm Business Overview

7.16.3 Dance Biopharm Home Insulin Delivery (Dosing) Devices Major Product Offerings

7.16.4 Dance Biopharm Home Insulin Delivery (Dosing) Devices Sales and Revenue in Global (2017-2022)

7.16.5 Dance Biopharm Key News

7.17 Debiotech

7.17.1 Debiotech Corporate Summary

7.17.2 Debiotech Business Overview

7.17.3 Debiotech Home Insulin Delivery (Dosing) Devices Major Product Offerings

7.17.4 Debiotech Home Insulin Delivery (Dosing) Devices Sales and Revenue in Global (2017-2022)

7.17.5 Debiotech Key News

7.18 MannKind

7.18.1 MannKind Corporate Summary

7.18.2 MannKind Business Overview

7.18.3 MannKind Home Insulin Delivery (Dosing) Devices Major Product Offerings

7.18.4 MannKind Home Insulin Delivery (Dosing) Devices Sales and Revenue in Global (2017-2022)

7.18.5 MannKind Key News

7.19 Owen Mumford

7.19.1 Owen Mumford Corporate Summary

7.19.2 Owen Mumford Business Overview

7.19.3 Owen Mumford Home Insulin Delivery (Dosing) Devices Major Product Offerings

7.19.4 Owen Mumford Home Insulin Delivery (Dosing) Devices Sales and Revenue in Global (2017-2022)

7.19.5 Owen Mumford Key News

7.20 SOOIL

7.20.1 SOOIL Corporate Summary

7.20.2 SOOIL Business Overview

7.20.3 SOOIL Home Insulin Delivery (Dosing) Devices Major Product Offerings

7.20.4 SOOIL Home Insulin Delivery (Dosing) Devices Sales and Revenue in Global (2017-2022)

7.20.5 SOOIL Key News

7.21 Valeritas

7.21.1 Valeritas Corporate Summary

7.21.2 Valeritas Business Overview

7.21.3 Valeritas Home Insulin Delivery (Dosing) Devices Major Product Offerings

7.21.4 Valeritas Home Insulin Delivery (Dosing) Devices Sales and Revenue in Global (2017-2022)

7.21.5 Valeritas Key News

7.22 West Pharma

7.22.1 West Pharma Corporate Summary

7.22.2 West Pharma Business Overview

7.22.3 West Pharma Home Insulin Delivery (Dosing) Devices Major Product Offerings

7.22.4 West Pharma Home Insulin Delivery (Dosing) Devices Sales and Revenue in Global (2017-2022)

7.22.5 West Pharma Key News

8 Global Home Insulin Delivery (Dosing) Devices Production Capacity, Analysis

8.1 Global Home Insulin Delivery (Dosing) Devices Production Capacity, 2017-2028

8.2 Home Insulin Delivery (Dosing) Devices Production Capacity of Key Manufacturers in Global Market

8.3 Global Home Insulin Delivery (Dosing) Devices Production by Region

9 Key Market Trends, Opportunity, Drivers and Restraints

9.1 Market Opportunities & Trends

9.2 Market Drivers

9.3 Market Restraints

10 Home Insulin Delivery (Dosing) Devices Supply Chain Analysis

10.1 Home Insulin Delivery (Dosing) Devices Industry Value Chain

10.2 Home Insulin Delivery (Dosing) Devices Upstream Market

10.3 Home Insulin Delivery (Dosing) Devices Downstream and Clients

10.4 Marketing Channels Analysis

10.4.1 Marketing Channels

10.4.2 Home Insulin Delivery (Dosing) Devices Distributors and Sales Agents in Global

11 Conclusion

12 Appendix

12.1 Note

12.2 Examples of Clients

12.3 Disclaimer

List of Tables

Table 1. Key Players of Home Insulin Delivery (Dosing) Devices in Global Market

Table 2. Top Home Insulin Delivery (Dosing) Devices Players in Global Market, Ranking by Revenue (2021)

Table 3. Global Home Insulin Delivery (Dosing) Devices Revenue by Companies, (US$, Mn), 2017-2022

Table 4. Global Home Insulin Delivery (Dosing) Devices Revenue Share by Companies, 2017-2022

Table 5. Global Home Insulin Delivery (Dosing) Devices Sales by Companies, (K Units), 2017-2022

Table 6. Global Home Insulin Delivery (Dosing) Devices Sales Share by Companies, 2017-2022

Table 7. Key Manufacturers Home Insulin Delivery (Dosing) Devices Price (2017-2022) & (US$/Unit)

Table 8. Global Manufacturers Home Insulin Delivery (Dosing) Devices Product Type

Table 9. List of Global Tier 1 Home Insulin Delivery (Dosing) Devices Companies, Revenue (US$, Mn) in 2021 and Market Share

Table 10. List of Global Tier 2 and Tier 3 Home Insulin Delivery (Dosing) Devices Companies, Revenue (US$, Mn) in 2021 and Market Share

Table 11. By Type – Global Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2021 & 2028

Table 12. By Type - Global Home Insulin Delivery (Dosing) Devices Revenue (US$, Mn), 2017-2022

Table 13. By Type - Global Home Insulin Delivery (Dosing) Devices Revenue (US$, Mn), 2023-2028

Table 14. By Type - Global Home Insulin Delivery (Dosing) Devices Sales (K Units), 2017-2022

Table 15. By Type - Global Home Insulin Delivery (Dosing) Devices Sales (K Units), 2023-2028

Table 16. By Application – Global Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2021 & 2028

Table 17. By Application - Global Home Insulin Delivery (Dosing) Devices Revenue (US$, Mn), 2017-2022

Table 18. By Application - Global Home Insulin Delivery (Dosing) Devices Revenue (US$, Mn), 2023-2028

Table 19. By Application - Global Home Insulin Delivery (Dosing) Devices Sales (K Units), 2017-2022

Table 20. By Application - Global Home Insulin Delivery (Dosing) Devices Sales (K Units), 2023-2028

Table 21. By Region – Global Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2021 VS 2028

Table 22. By Region - Global Home Insulin Delivery (Dosing) Devices Revenue (US$, Mn), 2017-2022

Table 23. By Region - Global Home Insulin Delivery (Dosing) Devices Revenue (US$, Mn), 2023-2028

Table 24. By Region - Global Home Insulin Delivery (Dosing) Devices Sales (K Units), 2017-2022

Table 25. By Region - Global Home Insulin Delivery (Dosing) Devices Sales (K Units), 2023-2028

Table 26. By Country - North America Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2017-2022

Table 27. By Country - North America Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2023-2028

Table 28. By Country - North America Home Insulin Delivery (Dosing) Devices Sales, (K Units), 2017-2022

Table 29. By Country - North America Home Insulin Delivery (Dosing) Devices Sales, (K Units), 2023-2028

Table 30. By Country - Europe Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2017-2022

Table 31. By Country - Europe Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2023-2028

Table 32. By Country - Europe Home Insulin Delivery (Dosing) Devices Sales, (K Units), 2017-2022

Table 33. By Country - Europe Home Insulin Delivery (Dosing) Devices Sales, (K Units), 2023-2028

Table 34. By Region - Asia Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2017-2022

Table 35. By Region - Asia Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2023-2028

Table 36. By Region - Asia Home Insulin Delivery (Dosing) Devices Sales, (K Units), 2017-2022

Table 37. By Region - Asia Home Insulin Delivery (Dosing) Devices Sales, (K Units), 2023-2028

Table 38. By Country - South America Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2017-2022

Table 39. By Country - South America Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2023-2028

Table 40. By Country - South America Home Insulin Delivery (Dosing) Devices Sales, (K Units), 2017-2022

Table 41. By Country - South America Home Insulin Delivery (Dosing) Devices Sales, (K Units), 2023-2028

Table 42. By Country - Middle East & Africa Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2017-2022

Table 43. By Country - Middle East & Africa Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2023-2028

Table 44. By Country - Middle East & Africa Home Insulin Delivery (Dosing) Devices Sales, (K Units), 2017-2022

Table 45. By Country - Middle East & Africa Home Insulin Delivery (Dosing) Devices Sales, (K Units), 2023-2028

Table 46. Tandem Diabetes Care Corporate Summary

Table 47. Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Product Offerings

Table 48. Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)

Table 49. Biocon Corporate Summary

Table 50. Biocon Home Insulin Delivery (Dosing) Devices Product Offerings

Table 51. Biocon Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)

Table 52. Roche Holding AG Corporate Summary

Table 53. Roche Holding AG Home Insulin Delivery (Dosing) Devices Product Offerings

Table 54. Roche Holding AG Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)

Table 55. Insulet Corporation Corporate Summary

Table 56. Insulet Corporation Home Insulin Delivery (Dosing) Devices Product Offerings

Table 57. Insulet Corporation Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)

Table 58. B. Braun Corporate Summary

Table 59. B. Braun Home Insulin Delivery (Dosing) Devices Product Offerings

Table 60. B. Braun Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)

Table 61. BD Corporate Summary

Table 62. BD Home Insulin Delivery (Dosing) Devices Product Offerings

Table 63. BD Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)

Table 64. Eli Lilly and Company Corporate Summary

Table 65. Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Product Offerings

Table 66. Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)

Table 67. Novo Nordisk Corporate Summary

Table 68. Novo Nordisk Home Insulin Delivery (Dosing) Devices Product Offerings

Table 69. Novo Nordisk Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)

Table 70. Sanofi Corporate Summary

Table 71. Sanofi Home Insulin Delivery (Dosing) Devices Product Offerings

Table 72. Sanofi Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)

Table 73. Wockhardt Corporate Summary

Table 74. Wockhardt Home Insulin Delivery (Dosing) Devices Product Offerings

Table 75. Wockhardt Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)

Table 76. Ypsomed Holding Corporate Summary

Table 77. Ypsomed Holding Home Insulin Delivery (Dosing) Devices Product Offerings

Table 78. Ypsomed Holding Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)

Table 79. Medtronic Corporate Summary

Table 80. Medtronic Home Insulin Delivery (Dosing) Devices Product Offerings

Table 81. Medtronic Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)

Table 82. Julphar Corporate Summary

Table 83. Julphar Home Insulin Delivery (Dosing) Devices Product Offerings

Table 84. Julphar Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)

Table 85. Beta Bionics Corporate Summary

Table 86. Beta Bionics Home Insulin Delivery (Dosing) Devices Product Offerings

Table 87. Beta Bionics Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)

Table 88. Copernicus Corporate Summary

Table 89. Copernicus Home Insulin Delivery (Dosing) Devices Product Offerings

Table 90. Copernicus Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)

Table 91. Dance Biopharm Corporate Summary

Table 92. Dance Biopharm Home Insulin Delivery (Dosing) Devices Product Offerings

Table 93. Dance Biopharm Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)

Table 94. Debiotech Corporate Summary

Table 95. Debiotech Home Insulin Delivery (Dosing) Devices Product Offerings

Table 96. Debiotech Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)

Table 97. MannKind Corporate Summary

Table 98. MannKind Home Insulin Delivery (Dosing) Devices Product Offerings

Table 99. MannKind Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)

Table 100. Owen Mumford Corporate Summary

Table 101. Owen Mumford Home Insulin Delivery (Dosing) Devices Product Offerings

Table 102. Owen Mumford Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)

Table 103. SOOIL Corporate Summary

Table 104. SOOIL Home Insulin Delivery (Dosing) Devices Product Offerings

Table 105. SOOIL Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)

Table 106. Valeritas Corporate Summary

Table 107. Valeritas Home Insulin Delivery (Dosing) Devices Product Offerings

Table 108. Valeritas Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)

Table 109. West Pharma Corporate Summary

Table 110. West Pharma Home Insulin Delivery (Dosing) Devices Product Offerings

Table 111. West Pharma Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)

Table 112. Home Insulin Delivery (Dosing) Devices Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)

Table 113. Global Home Insulin Delivery (Dosing) Devices Capacity Market Share of Key Manufacturers, 2020-2022

Table 114. Global Home Insulin Delivery (Dosing) Devices Production by Region, 2017-2022 (K Units)

Table 115. Global Home Insulin Delivery (Dosing) Devices Production by Region, 2023-2028 (K Units)

Table 116. Home Insulin Delivery (Dosing) Devices Market Opportunities & Trends in Global Market

Table 117. Home Insulin Delivery (Dosing) Devices Market Drivers in Global Market

Table 118. Home Insulin Delivery (Dosing) Devices Market Restraints in Global Market

Table 119. Home Insulin Delivery (Dosing) Devices Raw Materials

Table 120. Home Insulin Delivery (Dosing) Devices Raw Materials Suppliers in Global Market

Table 121. Typical Home Insulin Delivery (Dosing) Devices Downstream

Table 122. Home Insulin Delivery (Dosing) Devices Downstream Clients in Global Market

Table 123. Home Insulin Delivery (Dosing) Devices Distributors and Sales Agents in Global Market

List of Figures

Figure 1. Home Insulin Delivery (Dosing) Devices Segment by Type

Figure 2. Home Insulin Delivery (Dosing) Devices Segment by Application

Figure 3. Global Home Insulin Delivery (Dosing) Devices Market Overview: 2021

Figure 4. Key Caveats

Figure 5. Global Home Insulin Delivery (Dosing) Devices Market Size: 2021 VS 2028 (US$, Mn)

Figure 6. Global Home Insulin Delivery (Dosing) Devices Revenue, 2017-2028 (US$, Mn)

Figure 7. Home Insulin Delivery (Dosing) Devices Sales in Global Market: 2017-2028 (K Units)

Figure 8. The Top 3 and 5 Players Market Share by Home Insulin Delivery (Dosing) Devices Revenue in 2021

Figure 9. By Type - Global Home Insulin Delivery (Dosing) Devices Sales Market Share, 2017-2028

Figure 10. By Type - Global Home Insulin Delivery (Dosing) Devices Revenue Market Share, 2017-2028

Figure 11. By Type - Global Home Insulin Delivery (Dosing) Devices Price (US$/Unit), 2017-2028

Figure 12. By Application - Global Home Insulin Delivery (Dosing) Devices Sales Market Share, 2017-2028

Figure 13. By Application - Global Home Insulin Delivery (Dosing) Devices Revenue Market Share, 2017-2028

Figure 14. By Application - Global Home Insulin Delivery (Dosing) Devices Price (US$/Unit), 2017-2028

Figure 15. By Region - Global Home Insulin Delivery (Dosing) Devices Sales Market Share, 2017-2028

Figure 16. By Region - Global Home Insulin Delivery (Dosing) Devices Revenue Market Share, 2017-2028

Figure 17. By Country - North America Home Insulin Delivery (Dosing) Devices Revenue Market Share, 2017-2028

Figure 18. By Country - North America Home Insulin Delivery (Dosing) Devices Sales Market Share, 2017-2028

Figure 19. US Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2017-2028

Figure 20. Canada Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2017-2028

Figure 21. Mexico Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2017-2028

Figure 22. By Country - Europe Home Insulin Delivery (Dosing) Devices Revenue Market Share, 2017-2028

Figure 23. By Country - Europe Home Insulin Delivery (Dosing) Devices Sales Market Share, 2017-2028

Figure 24. Germany Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2017-2028

Figure 25. France Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2017-2028

Figure 26. U.K. Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2017-2028

Figure 27. Italy Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2017-2028

Figure 28. Russia Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2017-2028

Figure 29. Nordic Countries Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2017-2028

Figure 30. Benelux Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2017-2028

Figure 31. By Region - Asia Home Insulin Delivery (Dosing) Devices Revenue Market Share, 2017-2028

Figure 32. By Region - Asia Home Insulin Delivery (Dosing) Devices Sales Market Share, 2017-2028

Figure 33. China Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2017-2028

Figure 34. Japan Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2017-2028

Figure 35. South Korea Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2017-2028

Figure 36. Southeast Asia Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2017-2028

Figure 37. India Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2017-2028

Figure 38. By Country - South America Home Insulin Delivery (Dosing) Devices Revenue Market Share, 2017-2028

Figure 39. By Country - South America Home Insulin Delivery (Dosing) Devices Sales Market Share, 2017-2028

Figure 40. Brazil Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2017-2028

Figure 41. Argentina Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2017-2028

Figure 42. By Country - Middle East & Africa Home Insulin Delivery (Dosing) Devices Revenue Market Share, 2017-2028

Figure 43. By Country - Middle East & Africa Home Insulin Delivery (Dosing) Devices Sales Market Share, 2017-2028

Figure 44. Turkey Home Insulin Delivery (Dosing) Devices Revenue, (US$, Mn), 2017-2028

Figure 45. Israel Home Insulin Delivery (Dosing) Devices

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)